Carmustine and Baker's antifol combination chemotherapy for primary brain tumors progressive after irradiation and chemotherapy.
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001254:Astrocytoma / Q000188:drug therapy*; D001772:Blood Cell Count; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy; D002330:Carmustine / Q000008:administration & dosage; D003131:Combined Modality Therapy; D004334:Drug Administration Schedule; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D014227:Triazines / Q000008:administration & dosage
D014227:Triazines; C012071:triazinate; D002330:Carmustine